Published in J Nutr on March 01, 1995
Dietary fats and prevention of type 2 diabetes. Prog Lipid Res (2008) 3.01
Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids (2010) 1.75
Comparison of lipid profile and antioxidant enzymes among south Indian men consuming coconut oil and sunflower oil. Indian J Clin Biochem (2009) 0.96
Skeletal muscle insulin resistance: the interplay of local lipid excess and mitochondrial dysfunction. Metabolism (2009) 0.95
Effect of dietary fatty acid composition on substrate utilization and body weight maintenance in humans. Eur J Nutr (2013) 0.85
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet (2005) 13.18
Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia (1992) 5.25
A comparison of diets with and without oats in adults with celiac disease. N Engl J Med (1995) 4.14
Association between dental health and acute myocardial infarction. BMJ (1989) 3.94
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation (2005) 2.77
Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol (1990) 2.56
Thyroid storm prior to induction of anaesthesia. Anaesthesia (2004) 2.43
Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia (1993) 2.41
Social alcohol consumption and low Lp(a) lipoprotein concentrations in middle aged Finnish men: population based study. BMJ (1998) 2.16
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. Int J Obes (Lond) (2011) 2.08
Apolipoprotein E phenotype determines the effect of alcohol on blood pressure in middle-aged men. Am J Hypertens (1998) 2.02
Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia (2010) 1.88
Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness. Eur J Clin Invest (2001) 1.54
Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? Gastroenterology (1996) 1.54
Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet Med (2002) 1.52
Sex-related differences in autonomic modulation of heart rate in middle-aged subjects. Circulation (1996) 1.50
Polymorphisms of genes affecting thrombosis and risk of myocardial infarction. Eur J Clin Invest (2002) 1.49
Nutritional status of newly diagnosed celiac disease patients before and after the institution of a celiac disease diet--association with the grade of mucosal villous atrophy. Am J Clin Nutr (1998) 1.49
Apolipoprotein B gene polymorphisms and serum lipids: meta-analysis of the role of genetic variation in responsiveness to diet. Am J Clin Nutr (2000) 1.47
Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology (2006) 1.45
Apolipoprotein E phenotype and blood pressure. Lancet (1994) 1.45
Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men. Metabolism (1989) 1.33
Prevalence and prognosis of subjects with Brugada-type ECG pattern in a young and middle-aged Finnish population. Eur Heart J (2004) 1.32
Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ (1994) 1.29
Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med (1999) 1.27
Apolipoprotein E and B polymorphisms--longevity factors assessed in nonagenarians. Atherosclerosis (1994) 1.25
Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest (1987) 1.25
A rapid increase in lipoprotein (a) levels after ethanol withdrawal in alcoholic men. Life Sci (1991) 1.24
Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group. Eur J Clin Invest (1999) 1.24
5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Circulation (1990) 1.22
Medial artery calcification predicts cardiovascular mortality in patients with NIDDM. Diabetes Care (1994) 1.20
Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat Med (1998) 1.20
Lack of cellular and humoral immunological responses to oats in adults with coeliac disease. Gut (2000) 1.20
Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart (1996) 1.17
Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease. J Lipid Res (1995) 1.14
Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects. Am J Clin Nutr (1999) 1.13
The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction : a substudy of the Scandinavian simvastatin survival study. Circulation (2000) 1.13
APOE polymorphism and the hypertriglyceridemic effect of dietary sucrose. Am J Clin Nutr (2001) 1.13
Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease. Arterioscler Thromb Vasc Biol (2000) 1.12
Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome -- a randomized study (SYSDIET). J Intern Med (2013) 1.12
Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. J Intern Med (2001) 1.10
Effects of alcohol on lipoproteins in relation to coronary heart disease. Curr Opin Lipidol (1995) 1.10
Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med (2000) 1.09
GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis. Diabetes Care (1995) 1.09
Hormonal regulation of hepatic soluble phosphatidate phosphohydrolase. Induction by cortisol in vivo and in isolated perfused rat liver. FEBS Lett (1979) 1.09
Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten-year follow-up from the diagnosis. Diabetes (1996) 1.07
1H NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma. J Lipid Res (1994) 1.07
Aerobic exercise and the lipid profile in type 1 diabetic men: a randomized controlled trial. Med Sci Sports Exerc (2000) 1.06
Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins. J Clin Invest (1985) 1.06
Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease. J Clin Invest (1985) 1.06
Stimulation of hepatic phosphatidate phosphohydrolase activity by a single dose of ethanol;. Biochem Biophys Res Commun (1977) 1.05
Fatty acid composition of serum cholesterol esters, and erythrocyte and platelet membranes as indicators of long-term adherence to fat-modified diets. Am J Clin Nutr (1994) 1.04
Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients. Diabet Med (2005) 1.03
Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet. Eur J Clin Nutr (2000) 1.03
Occurrence and predictors of retinopathy and visual acuity in Type 2 diabetic patients and control subjects. 10-year follow-up from the diagnosis. J Diabetes Complications (2001) 1.03
Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res (1992) 1.03
Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity. Obes Res (2001) 1.02
Trends in coronary events in Finland during 1983-1997. The FINAMI study. Eur Heart J (2003) 1.02
Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol (1995) 1.01
Apolipoprotein E phenotype, cholesterol and breast and prostate cancer. J Epidemiol Community Health (2000) 1.01
Lower-extremity amputations in diabetic and nondiabetic patients. A population-based study in eastern Finland. Diabetes Care (1993) 1.00
Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans. FASEB J (2001) 1.00
Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy. Br J Ophthalmol (2009) 1.00
Aortic and lower limb artery calcification in type 2 (non-insulin-dependent) diabetic patients and non-diabetic control subjects. A five year follow-up study. Atherosclerosis (1990) 1.00
Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men. Atherosclerosis (2001) 0.99
Regional cerebral blood flow during food exposure in obese and normal-weight women. Brain (1997) 0.99
Apolipoprotein E phenotype alone does not influence survival in Alzheimer's disease: a population-based longitudinal study. Neuroepidemiology (2000) 0.98
Carbamylation-induced alterations in low-density lipoprotein metabolism. Kidney Int (1992) 0.98
Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women. J Nutr (2001) 0.98
Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med (2002) 0.98
High vitreous concentration of IL-6 and IL-8, but not of adhesion molecules in relation to plasma concentrations in proliferative diabetic retinopathy. Ophthalmic Res (2012) 0.97
Cholesterol absorption: regulation of cholesterol synthesis and elimination and within-population variations of serum cholesterol levels. Am J Clin Nutr (1989) 0.97
Myocardial fatty acid oxidation in patients with impaired glucose tolerance. Diabetologia (2001) 0.97
Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes. J Intern Med (2011) 0.96
Identification of new sequence variants in the leptin gene. J Clin Endocrinol Metab (1998) 0.96